Blood, 0006-4971

Journal

Publications

  1. 2020
  2. Published

    Genetics in the era of targeted CLL therapy

    Tatjana Stankovic & Marwan Cheng Kuang Kwok, 25 Jun 2020, In : Blood. 135, 26, p. 2333-2334 2 p.

    Research output: Contribution to journalComment/debate

  3. Published
  4. Accepted/In press

    GERMLINE TET2 LOSS-OF-FUNCTION CAUSES CHILDHOOD IMMUNODEFICIENCY AND LYMPHOMA

    Neil Morgan & 7 others, , 9 Jun 2020, (Accepted/In press) In : Blood.

    Research output: Contribution to journalArticle

  5. Published

    Interplay between the tyrosine kinases Chk, Csk and phosphatase PTPRJ is critical for regulating platelets in mice

    Zoltan Nagy, Jun Mori & Yotis Senis, 30 Apr 2020, In : Blood. 135, 18, p. 1574–1587 14 p.

    Research output: Contribution to journalArticle

  6. Published

    Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, 27 Feb 2020, In : Blood. 135, 9, p. 680-688 9 p.

    Research output: Contribution to journalArticle

  7. Published
  8. 2019
  9. Published

    JAK2 mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms

    Sarah Dimeloe & 10 others, , 21 Nov 2019, In : Blood. 134, 21, p. 1832-1846 15 p.

    Research output: Contribution to journalArticle

  10. Published
  11. Published
  12. 2018
  13. Published

    Identification and characterisation of a novel antioxidant activity for the BCAT1 CXXC motif: implications for myeloid leukaemia development

    Alex Wadley, 29 Nov 2018, In : Blood. 132, Supplement 1, 1473.

    Research output: Contribution to journalConference article

Previous 1 2 3 4 5 6 7 8 ...31 Next